Evaluation of medicinal products for cardiovascular disease prevention

  • Email
  • Help
Current effective version

Adopted guideline

Reference numberCHMP/EWP/311890/07
Effective from01/04//2009
KeywordsCardiovascular prevention, risk scoring models, SCORE system, Framingham risk score
DescriptionThis document provides guidance for the clinical evaluation of drugs in the prevention of cardiovascular events.

Document history

First version

Current version

Adopted guideline

Overview of comments

Draft guideline

Concept paper

In operation: 01/04/2009–present

Published: 24/07/2008

Published: 19/07/2007

Published: 23/06/2004

Related content

How helpful is this page?

Average rating:

 Based on 15 ratings

Add your rating:

See all ratings
3 ratings
3 ratings
3 ratings
3 ratings
3 ratings

Tell us more